Open access
175
Views
25
CrossRef citations to date
0
Altmetric
Original Research
Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
Haitao Pan1 School of Pharmaceutical Sciences;2 Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People’s Republic of China
, Jiayu Liu1 School of Pharmaceutical Sciences;2 Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People’s Republic of China
, Wentong Deng1 School of Pharmaceutical Sciences;2 Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People’s Republic of China
, Jieyu Xing1 School of Pharmaceutical Sciences;2 Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People’s Republic of China
, Qing Li1 School of Pharmaceutical Sciences;2 Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
& Zhong Wang1 School of Pharmaceutical Sciences;2 Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
Pages 3189-3201
|
Published online: 29 May 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.